Back to results
US 10,851,092 B2Granted
Pyridine compound
AssigneeDaiichi Sankyo Company, Limited
InventorsHiroaki Inagaki, Yoshihiro Shibata, Hidenori Namiki, Hideaki Kageji, Kiyoshi Nakayama, Yasuyuki Kaneta
Life of this patent
Estimating the term…
Abstract
The present invention relates to a compound having RET kinase inhibiting action or a pharmaceutically acceptable salt thereof, useful in the treatment of diseases such as cancer. In particular a compound represented by the following general formula (I) as defined herein: (I) or a pharmaceutically acceptable salt thereof.
Claims13
A compound represented by the following general formula (I):
- wherein A represents one selected from the following formulae (Ia) to (Id):
- wherein R1 represents a hydrogen atom or a C1-C3 alkyl group, and R2 represents a hydrogen atom or a C1-C3 alkyl group, or
- a pharmaceutically acceptable salt thereof.
Dependencies are inferred from the claim text.